Structure-based antigen design: a strategy for next generation vaccines

[1]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[2]  M. Kalin,et al.  Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies , 2008, The Journal of experimental medicine.

[3]  Rino Rappuoli,et al.  Bridging the knowledge gaps in vaccine design , 2007, Nature Biotechnology.

[4]  J. Snyder,et al.  Reversible Inhibition of the Fusion Activity of Measles Virus F Protein by an Engineered Intersubunit Disulfide Bridge , 2007, Journal of Virology.

[5]  James McCluskey,et al.  More than one reason to rethink the use of peptides in vaccine design , 2007, Nature Reviews Drug Discovery.

[6]  Tongqing Zhou,et al.  Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.

[7]  Wim Jiskoot,et al.  A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals* , 2007, Journal of Biological Chemistry.

[8]  D. Wildman,et al.  Functionally important glycosyltransferase gain and loss during catarrhine primate emergence , 2007, Proceedings of the National Academy of Sciences.

[9]  R. Rappuoli,et al.  A universal vaccine for serogroup B meningococcus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Shixia Wang,et al.  Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered To Express Galα1-3Galβ1-4GlcNAc-R Epitopes , 2006, Journal of Virology.

[11]  P. Dormitzer,et al.  Alternative intermolecular contacts underlie the rotavirus VP5* two‐ to three‐fold rearrangement , 2006, The EMBO journal.

[12]  L. McCallum,et al.  The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB , 2006, Clinical and Vaccine Immunology.

[13]  P. Dormitzer,et al.  High-Resolution Molecular and Antigen Structure of the VP8* Core of a Sialic Acid-Independent Human Rotavirus Strain , 2006, Journal of Virology.

[14]  R. Lamb,et al.  Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation , 2006, Nature.

[15]  Gennaro Ciliberto,et al.  A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  David I Stuart,et al.  Hepatitis B small surface antigen particles are octahedral. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Harrison,et al.  Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.

[18]  H. Tettelin,et al.  Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen , 2005, Science.

[19]  R. Lamb,et al.  Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Alasdair C. Steven,et al.  The Structure of the Poliovirus 135S Cell Entry Intermediate at 10-Angstrom Resolution Reveals the Location of an Externalized Polypeptide That Binds to Membranes , 2005, Journal of Virology.

[21]  Brett D. Welch,et al.  Steric Accessibility of the HIV-1 gp41 N-trimer Region* , 2005, Journal of Biological Chemistry.

[22]  S. Lesley,et al.  High-throughput Protein Production for X-ray Crystallography and Use of Size Exclusion Chromatography to Validate or Refute Computational Biological Unit Predictions , 2005, Journal of Structural and Functional Genomics.

[23]  S. Harrison,et al.  Structural rearrangements in the membrane penetration protein of a non-enveloped virus , 2004, Nature.

[24]  Wayne C Koff,et al.  HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.

[25]  R. Desrosiers,et al.  Removal of N-Linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus gp120 Results in Redirection of B-Cell Responses to V3 , 2004, Journal of Virology.

[26]  R. Lamb,et al.  A dual-functional paramyxovirus F protein regulatory switch segment , 2003, The Journal of cell biology.

[27]  C. Fraser,et al.  Functional Selection of Vaccine Candidate Peptides from Staphylococcus aureus Whole-Genome Expression Libraries In Vitro , 2003, Infection and Immunity.

[28]  Dennis R. Burton,et al.  Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design , 2003, Journal of Virology.

[29]  L. Stamatatos,et al.  Changes in the Immunogenic Properties of Soluble gp140 Human Immunodeficiency Virus Envelope Constructs upon Partial Deletion of the Second Hypervariable Region , 2003, Journal of Virology.

[30]  N. Cox,et al.  Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. , 2003, Virology.

[31]  Rino Rappuoli,et al.  Reverse vaccinology. , 2000, Current opinion in microbiology.

[32]  G. Air,et al.  Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98) , 2002, Journal of Virology.

[33]  Steven Henikoff,et al.  Affinity Selection from Biological Libraries , 2002, Science.

[34]  Y. Modis,et al.  Atomic model of the papillomavirus capsid , 2002, The EMBO journal.

[35]  F. Liprandi,et al.  Antibodies to Rotavirus Outer Capsid Glycoprotein VP7 Neutralize Infectivity by Inhibiting Virion Decapsidation , 2002, Journal of Virology.

[36]  J. Mandell,et al.  Epitope mapping of a monoclonal antibody against human thrombin by H/D‐exchange mass spectrometry reveals selection of a diverse sequence in a highly conserved protein , 2002, Protein science : a publication of the Protein Society.

[37]  Gerhard Wagner,et al.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site , 2002, The EMBO journal.

[38]  M. Yeager,et al.  Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry. , 2001, Journal of molecular biology.

[39]  S. Harrison,et al.  Purified recombinant rotavirus VP7 forms soluble, calcium-dependent trimers. , 2000, Virology.

[40]  J. Venter,et al.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. , 2000, Science.

[41]  R. Rappuoli.  Reverse vaccinology : Genomics , 2000 .

[42]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[43]  C. Barbas,et al.  Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. , 1998, Virology.

[44]  L. Stamatatos,et al.  An Envelope Modification That Renders a Primary, Neutralization-Resistant Clade B Human Immunodeficiency Virus Type 1 Isolate Highly Susceptible to Neutralization by Sera from Other Clades , 1998, Journal of Virology.

[45]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[46]  Peter D. Kwong,et al.  The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.

[47]  R. Means,et al.  A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.

[48]  T. Marlovits,et al.  Structure of a Neutralizing Antibody Bound Monovalently to Human Rhinovirus 2 , 1998, Journal of Virology.

[49]  R. Zinkernagel,et al.  Neutralizing antiviral B cell responses. , 1997, Annual review of immunology.

[50]  Pascal Rigolet,et al.  Structure of influenza virus haemagglutinin complexed with a neutralizing antibody , 1995, Nature.

[51]  P. Dormitzer,et al.  Presentation of neutralizing epitopes by engineered rotavirus VP7's expressed by recombinant vaccinia viruses. , 1994, Virology.

[52]  J. Sodroski,et al.  Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.

[53]  P. Dormitzer,et al.  Calcium chelation induces a conformational change in recombinant herpes simplex virus-1-expressed rotavirus VP7. , 1992, Virology.

[54]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[55]  P. Dormitzer,et al.  Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. , 1992, Virology.

[56]  J. Skehel,et al.  Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity , 1992, Cell.

[57]  A. Bellamy,et al.  Relocation of antigens to the cell surface membrane can enhance immune stimulation and protection , 1992, Immunology and cell biology.

[58]  J. Poolman,et al.  Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines , 1991, Infection and immunity.

[59]  H. Greenberg,et al.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture , 1991, Journal of virology.

[60]  H. Greenberg,et al.  Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge , 1990, Journal of virology.

[61]  L. Nencioni,et al.  Mutants of pertussis toxin suitable for vaccine development. , 1989, Science.

[62]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[63]  F. Michelangeli,et al.  Penetration and uncoating of rotaviruses in cultured cells. , 1987, Intervirology.

[64]  D. Mckay,et al.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. Filman,et al.  Three-dimensional structure of poliovirus at 2.9 A resolution. , 1985, Science.

[66]  U. Galili,et al.  A Unique Natural Human Igg Antibody with Anti-a-galactosyl Specificity , 2022 .

[67]  I. Wilson,et al.  A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Cohen.  Ribonucleic acid polymerase activity associated with purified calf rotavirus. , 1977, The Journal of general virology.

[69]  R. Chanock,et al.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. , 1969, American journal of epidemiology.